Patanjali Ayurved witnesses demand of 10 lakh packs of Coronil daily

Yoga Guru Baba Ramdev said that Patanjali Ayurved is witnessing demand of around 10 lakh packs daily for its much controversial COVID-19 immunity booster medicine Coronil.

The Haridwar-based company is struggling to meet the demand as it is able to supply only around one lakh packs, Ramdev said.

"Today we have a demand of 10 lakh packs of Coronil daily and we are able to supply only one lakh," he claimed.

Stressing that Patanjali Ayurved had priced it only at Rs 500, Ramdev said, "Had we put a higher price of even Rs 5,000, in COVID-19 times, we could have easily earned up to Rs 5,000 crore from this. But we have not done so."

The yoga guru behind the ayurved enterprise was speaking at a virtual series organised by industry body ASSOCHAM on Aatmanirbhar Bharat - 'Vocal for Local'.

Earlier in June, Ramdev had claimed that Coronil can cure Covid-19 patients. However, the AYUSH Ministry immediately put restrictions on Patanjali over selling it.

Later, the Union ministry confirmed that Patanjali can sell the product only as an immunity booster but not as a cure for COVID-19.

The Madras High Court had restrained Patanjali from using the Coronil trademark till July 30, over a petition filed by a Chennai-based company.

Ramdev suggested industry leaders work with honesty to build a brand on which the people have trust and it needs a long term approach."To maintain that trust, you have to work honestly with dedication," he said.

"Now Patanjali has become a big brand, the success mantra of Patanjali is - knowledge, faith, respect and efforts only," he said.

Several companies mocked on us with derision saying that Patanjali has faith but not science, he added.

"Today we have over 500 scientists working for us. We could not have done this, if we had no knowledge about it," he said. Patanjali group has an estimated turnover of around 10,500 crore.

It had acquired debt-ridden Ruchi Soya in a corporate insolvency resolution process for around Rs 4,350 crore after competing with Adani Group.

Ayurved had reported a turnover of Rs 8,329 crore in FY 2018-19.

However, total turnover of the group was higher as Patanjali Ayurved consists of its FMCG business and Ayurvedic medicines.